Attys Agree To $143M Fee Split In $2.3B Avandia MDL

Law360, New York (January 22, 2013, 7:19 PM EST) -- Plaintiffs' attorneys on Thursday filed a plan in Pennsylvania federal court to split $143 million to resolve a fee dispute in what could be a $2.3 billion settlement in a massive multidistrict litigation over GlaxoSmithKline PLC's alleged failure to warn consumers about health risks related to its diabetes drug Avandia.

The judge overseeing the case had appointed a committee of eight attorneys who had worked on the case to come up with a fee allocation plan for the 58 lawyers and firms who had earned some...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.